Celldex Therapeutics (CLDX) Intangibles (2010 - 2026)

Celldex Therapeutics' Intangibles history runs 17 years deep, the most recent figure standing at $27.2 million for Q1 2026.

• In Q1 2026, Intangibles changed 0.0% year-over-year to $27.2 million; the TTM figure through Mar 2026 stood at $27.2 million (changed 0.0% YoY), while the FY2025 annual figure was $27.2 million, changed 0.04% from the prior year.
• Intangibles for Q1 2026 stood at $27.2 million, roughly flat from $27.2 million in the prior quarter.
• The five-year high for Intangibles was $27.2 million in Q2 2022, with the low at $27.2 million in Q1 2022.
• The 5-year median for Intangibles is $27.2 million (2022), against an average of $27.2 million.
• Peak annual rise in Intangibles reached 0.04% in 2022, while the deepest fall reached 11.43% in 2022.
• Celldex Therapeutics' Intangibles stood at $27.2 million in 2022, then changed by 0.0% to $27.2 million in 2023, then changed by 0.0% to $27.2 million in 2024, then decreased by 0.04% to $27.2 million in 2025, then changed by 0.0% to $27.2 million in 2026.
• Business Quant data shows CLDX's Intangibles at $27.2 million in Q1 2026, $27.2 million in Q4 2025, and $27.2 million in Q3 2025.